Fabtech Technologies working capital

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026
32.11×32.11×
181.57×181.57×
158.56×158.56×
55.12×55.12×
1.11×1.33×
0.63×0.63×
0.01×0.01×
0.01×0.01×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

FABTECH₹122.21

Fabtech Technologies Limited

· Pharma & Health
₹ CrorePeersLAXMIDENTLTARSONSFISCHERGKBMcap ₹543 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY26
31/03/2026
Last 12M
30/09/2026
Inventory Days (DIO)32.1132.11
Receivable Days (DSO)181.57181.57
Payable Days (DPO)158.56158.56
Cash Conversion Cycle (days)55.1255.12
Working Capital Turnover1.331.11
Asset Turnover0.630.63
Cash Conversion (CFO/Net Income)0.010.01
CFO/EBITDA0.010.01
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.